C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/80 (2006.01) A61K 31/44 (2006.01) A61P 5/48 (2006.01) A61P 11/06 (2006.01) A61P 17/04 (2006.01) A61P 17/06 (2006.01) A61P 29/00 (2006.01) A61P 31/14 (2006.01) A61P 31/18 (2006.01) A61P 31/20 (2006.01) A61P 35/02 (2006.01) A61P 35/04 (2006.01) C07D 213/82 (2006.01) C07D 405/04 (2006.01) C07D 405/12 (2006.01) C07D 409/04 (2006.01) C07D 409/14 (2006.01)
Patent
CA 2508171
A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of formula (I) is also described.
L'invention concerne un composé de formule générale (I) ou des promédicaments, sels, hydrates, solvates, formes cristallines ou diastéréoisomères acceptables sur le plan pharmaceutique de celui-ci. L'invention concerne également un procédé de traitement d'états pathologiques associés à la tyrosine kinase chez un sujet au moyen dudit composé.
Burns Christopher John
Kling Marcel Robert
Cytopia Pty Ltd
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Ym Biosciences Australia Pty Ltd
LandOfFree
Nicotinamide-based kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nicotinamide-based kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotinamide-based kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1733204